We evaluated the efficiency of this novel ASO design in correcting a common dominant mutation in COL6A3 gene (c.6210 + 1G>A) associated with Ullrich congenital muscular dystrophy (UCMD). Here, COL6A3 is linked to Ullrich congenital muscular dystrophy.